Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Harvard Business School
Merck
AstraZeneca
Boehringer Ingelheim

Last Updated: September 26, 2022

DURAPREP Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Duraprep, and what generic alternatives are available?

Duraprep is a drug marketed by 3M and is included in one NDA.

The generic ingredient in DURAPREP is iodine povacrylex; isopropyl alcohol. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iodine povacrylex; isopropyl alcohol profile page.

Summary for DURAPREP
Drug patent expirations by year for DURAPREP
Recent Clinical Trials for DURAPREP

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San DiegoPhase 4
Patient-Centered Outcomes Research InstitutePhase 4
University of Maryland, BaltimorePhase 4

See all DURAPREP clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for DURAPREP

US Patents and Regulatory Information for DURAPREP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m DURAPREP iodine povacrylex; isopropyl alcohol SPONGE;TOPICAL 021586-001 Sep 29, 2006 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
3m DURAPREP iodine povacrylex; isopropyl alcohol SPONGE;TOPICAL 021586-002 Sep 29, 2006 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Colorcon
Johnson and Johnson
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.